Xarelto vascular 2,5 mg, Filmtabletten - 100 Swissmedic Key 66872005 Registration Holder Bayer (Schweiz) AG Name Xarelto vascular 2,5 mg, Filmtabletten Date of registration 05.04.2019 Introduction of Sequence 05.04.2019 ATC-Classification Rivaroxaban (B01AF01) Revision date WHO WHO-DDD Valid until Index Therapeuticus (BSV) 06.03.40. Show package size 100 Index Therapeuticus (Swissmedic) 06.03. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680668720057 Medication Code Synthetika Pharmacode Disponibility
Composition rivaroxabanum 2.5 mg, cellulosum microcristallinum, carmellosum natricum conexum, hypromellosum, lactosum monohydricum 36 mg, magnesii stearas, natrii laurilsulfas, Überzug: hypromellosum, macrogolum 3350, E 171, E 172 (flavum), pro compresso obducto corresp. natrium 0.6 mg. Packungsbestandteile Galenic Form Coated tablets Active Agent Dose Rivaroxabanum 2.5 mg
BAG: Active Agent Dose Rivaroxabanum 2.5 mg
Inactive agents Dose additional_information (Flavum) Carmellosum Natricum Conexum Cellulosum Microcristallinum E 171 color. E 172 color. Hypromellosum Überzug Lactose Monohydrate 36 mg Macrogol 3350 Magnesii Stearas Natrii Laurilsulfas Pro Compresso Obducto
Source Data was imported : 07.07.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
